Skip to main content
Premium Trial:

Request an Annual Quote

Corvas Licenses Incyte s LifeSeq Gold Database

NEW YORK, Aug 1 –Corvas International has signed a multi-year subscription to Incyte’s LifeSeq Gold database, the companies said Wednesday.

Corvas said it would use the database for its cancer research activities. The San Diego-based company is currently researching serine proteases to determine their potential as solid tumor drug targets.

"We are integrating genome-based research with our expertise in serine protease therapeutics to expand the scope and potential proprietary position of our cancer programs," Randall Woods, CEO of Corvas, said in a statement.

"We believe access to new proteases afforded by Incyte's genomic database will facilitate our development of a leading position in the serine protease field," he said.

The LifeSeq Gold database offers information on expressed sequence tag and full-length gene sequences, mapping data, and public genomic sequence information.

Incyte of Palo Alto, Calif., did not disclose the financial terms of the non-exclusive deal.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.